Ticker Details
Penumbra, Inc. Penumbra Inc designs, develops, manufactures and markets medical devices. The products of the company address ischemic stroke, hemorrhagic stroke and vascular conditions that can be treated through thrombectomy and embolization procedures.
IPO Date:	September 18, 2015
Sector:	Healthcare
Industry:	Medical Devices
Market Cap:	$12.93B
Activated in VL:	True

Average Daily Range
Avg Daily Range:	$9.70 | 1.73%
Avg Daily Range (30 D):	$1.19 | 0.36%
Avg Daily Range (90 D):	$1.54 | 0.47%

Institutional Daily Volume
Avg Daily Volume:	.31M
Avg Daily Volume (30 D):	.38M
Avg Daily Volume (90 D):	.72M

Trade Size
Avg Trade Size (Sh.):	47
Avg Trade Size (Sh.) (30 D):	26
Avg Trade Size (Sh.) (90 D):	32

Institutional Trades
Total Institutional Trades:	4,114
Avg Institutional Trade:	$6.89M
Avg Institutional Trade (30 D):	$17.91M
Avg Institutional Trade (90 D):	$18.42M
Avg Institutional Trade Volume:	.03M
Avg Institutional Trades (Per Day):	1

Market Closing Trades
Avg Closing Trade:	$9.01M
Avg Closing Trade (30 D):	$24.28M
Avg Closing Trade (90 D):	$32.09M
Avg Closing Volume:	41.28K

News

May 17, 2026 @ 8:32 PM ServisFirst Gets Axed by Champlain — a Mino... Source: Seena Hassouna

Mar 5, 2026 @ 6:15 PM 3 Reasons Boston Scientific Stock Could Quietly 5X... Source: Eric Volkman

Feb 2, 2026 @ 10:49 PM Halper Sadeh LLC Reminds Shareholders of RAPT, PEN... Source: Halper Sadeh Llc

Jan 28, 2026 @ 7:23 PM $HAREHOLDER ALERT: The M&A Class Action Firm Is In... Source: Prnewswire

Jan 21, 2026 @ 9:52 PM Halper Sadeh LLC Encourages PEN, EXAS, DBRG, FFIC ... Source: Halper Sadeh Llc

Financials
	TTM	Q1 2026	Q4 2025
Basic EPS	$4.38	$.83	$1.21
Diluted EPS	$4.34	$.82	$1.2
Revenue	$1.45B	$374.76M	$385.39M
Gross Profit	$979.97M	$253.41M	$262.13M
Net Income / Loss	$171.05M	$32.58M	$47.34M
Operating Income / Loss	$187.13M	$38.23M	$59.23M
Cost of Revenue	$474.32M	$121.35M	$123.26M
Net Cash Flow	$-134.77M	$54.39M	$-134.13M
PE Ratio